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The free energy landscape concept that describes enzymes as an ensemble of differently populated conformational sub-
states in dynamic equilibrium is key for evaluating the enzyme activity, enantioselectivity, and specificity. Mutations 
introduced in the enzyme sequence can alter the populations of the pre-existing conformational states, thus strongly 
modifying the enzyme ability to accommodate alternative substrates, revert its enantiopreferences, and even increase the 
activity for some residual promiscuous reactions. In this feature article, we present an overview of the current 
experimental and computational strategies to explore the conformational free energy landscape of enzymes. We provide a 
series of recent publications that highlight the key role of conformational dynamics for the enzyme evolution towards new 
functions and substrates, and provide some perspectives on how conformational dynamism should be considered in future 
computational enzyme design protocols.  
 
1. Introduction 
Most enzymes are accurate, specific, and highly efficient in 
accelerating biotransformations. Their extraordinary catalytic 
power arises from their precisely pre-organised active sites 
that properly position the catalytic residues for efficient 
transition state (TS) stabilisation.1 This precise positioning of 
the catalytic machinery2 could be related to a lack of 
versatility. However, enzymes present a marked adaptability 
as shown by their capability of catalysing additional 
promiscuous side-reactions,3 and in their ability to evolve and 
acquire novel functions. In fact, evolvability of enzymes has 
been associated to their inherent dynamic nature.4 The ability 
of enzymes to visit different thermally accessible 
conformations, i.e. the enzyme conformational dynamics, 
plays a key role in enzyme promiscuity, regulation and 
inhibition, but also in essential steps in enzyme catalysis such 
as substrate binding, and product release.5 The existence of a 
link between active site dynamics and catalysis of the chemical 
step of the reaction has also long been debated.1a, 6 This 
observation is, however, totally independent to the fact that 
enzymes adopt multiple conformations along the catalytic 
cycle. 
Conformational changes in enzymes occur in a variety of 
timescales.7 Bond vibration (10-100 fs) and side-chain 
conformational changes (ps to μs) take place on the shortest 
timescales, whereas loop motions often key for substrate 
binding and product release occur in the nanosecond up to 
millisecond timescales. On the longest timescales, slow 
domain motions and allosteric transitions can take place (μs to 
s).8 All these motions can precede or occur after the chemical 
step, and indeed in some natural and laboratory-evolved 
enzymes conformational change is found to be rate-limiting.9 
Many examples have been provided in the literature 
highlighting the importance of engineering flexible loops and 
domains for novel function.10 Recent studies based on the 
analysis of static X-ray structures along evolutionary pathways 
and in ancestral protein reconstruction,11 nuclear magnetic 
resonance (NMR) experiments,9b, 12 and computational studies 
based on Molecular Dynamics (MD) simulations7c, 13 have 
provided further support of enzymes as an ensemble of 
thermally accessible conformations. All these evidences 
emphasise the crucial role of the enzyme conformational 
dynamics for its function.  
Initial attempts to computationally engineer enzymes 
towards non-natural reactions or substrates were based on 
protocols that (re)designed the active site of some natural 
scaffolds by mutating a subset of residues while maintaining 
most of the enzyme structure as rigid.14 Despite the initial 
successes, computationally designed enzymes display quite 
poor catalytic activities,14a and need to be further evolved by 
means of experimental techniques such as directed evolution 
(DE).15 The strategy of combining computational protocols and 
DE has been shown to be successful in designing enzymes for a 
broad scope of challenging transformations.2, 16 The origin 
behind the poor activities of computational designs has been 
attributed to the imperfect realization of the ideal 
arrangement of the catalytic residues for TS stabilization,17 and 
the tendency to consider only the chemical steps while 
overlooking essential conformational changes for substrate 
binding and product release.5a The latter observation suggests 
that the consideration of conformational dynamics in enzyme 
design could aid greatly the field. In fact, most recent enzyme 
design protocols take into consideration multiple states to 
better represent the enzyme conformational heterogeneity.18 
Advances in the available biophysical techniques and 
computational tools have contributed to a deeper 
understanding of the conformational dynamics of enzymes 
and their key role for activity.13a, 19 In this feature article, we 
provide an overview of the existing techniques that can be 
applied for characterising the enzyme free energy landscape. 
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We describe how by introducing mutations to the enzyme 
sequence the populations of the conformational states in the 
free energy landscape can be shifted for: enhancing a novel or 
promiscuous reaction, accepting alternative industrially-
relevant substrates, and altering the enzyme inherent 
enantioselectivity. We provide some representative examples 
recently published in the literature, combined with some 
recent publications from our lab. 
2. The conformational free energy landscape of 
proteins: theory and methodologies 
The broad range of conformations that enzymes can adopt in 
solution can be mapped into the so-called free energy 
landscape (see Fig. 1A). In this free energy landscape, the 
different conformational states (or sub-states) in thermal 
equilibrium are represented as well as the barriers separating 
them, thus obtaining information on the thermodynamics and 
kinetics of the system. The conformational sub-states in the 
free energy landscape are populated following statistical 
thermodynamic distributions. The regions with high 
populations of specific conformers correspond to either the 
local or global energy minima. The height of the barriers that 
separate the different conformational states dictate how fast 
or slow a conformational transition is. Therefore, 
conformational states separated by small energy barriers 
require ps-ns timescales to exchange, whereas if connected 
through high energy barriers the transition becomes slower 
and less likely to take place. It is also worth mentioning that, a 
particular free energy is linked to a specific protein sequence 
and defined values of temperature, pressure, and solvent 
conditions. Manipulating these parameters (e.g. single point 
mutation or a temperature increase) will result in dramatic 
changes in the relative conformational distributions or 
population shifts, but also in the kinetics of the conformational 
state interconversions. 
  The different conformational states that exist in the free 
energy landscape of enzymes and their rates of 
interconversion can be indirectly characterised through 
experimental methods. Collective or slow motions in proteins 
can be analysed thanks to X-ray crystallography, although 
there is a requirement for homogeneous crystals of individual 
states. Structural ensembles can be directly analysed thanks to 
cryo-electron microscopy, obviating the requirement for 
homogenous crystals, although at lower atomic resolution. 
This technique has been applied to determine the 
conformational energy landscape of yeast ribosome, together 
with RNA translocation as a function of time.20 NMR 
techniques, although also lacking the resolution of X-ray 
crystallography, provide structural together with kinetic data 
in a time scale range of picoseconds to seconds.9b, 21 Finally, 
biophysical techniques, such as fluorescence, circular 
dichroism, Raman spectroscopy, among others give kinetic 
information complementary to other structural methods.22  
Computational methods are particularly useful in 
reconstructing the free energy landscape of enzymes. The free 
energy (G) can be defined as the negative logarithm of the 
population distribution (P) in kBT units (e.g. kcal/mol⋅K; see eq. 
1), therefore a maximum in the distribution corresponds to a 
minimum in the free energy surface. By switching back and 
forth between stable states, their relative populations can be 
estimated.23 If the number of transitions increases, the error in 
the population estimation can be significantly reduced.   
G ∼ -kB T log (P) (1) 
 Molecular dynamics (MD) techniques allow to sample the 
population distribution of individual atoms or biomolecules by 
integrating Newton’s laws of motion. This enables the recovery 
of thermodynamic properties such as the free energy. 
Unfortunately, as a result of the large number of atoms 
present in simulations (ca. 100,000 atoms for a protein of 
regular size in an explicit solvent environment), this probability 
is defined in an extremely high dimensional space (see Fig. 1A). 
A natural solution to this limitation is to focus on a reduced set 
of global or collective degrees of freedom (DOFs), while less 
relevant atomic motions are averaged over the chosen DOFs. 
These DOFs can be any explicit function of the coordinates of 
the enzyme, relevant to the process of interest, such as 
distances between catalytic residues, backbone dihedral 
angles, or the RMSD of a loop. High dimensional data obtained 
from MD simulations can be projected onto these collective 
DOFs obtaining the probability distributions and reconstructing 
the free energy  (eq. 1).  
Reducing the dimensionality of our data to only a few DOFs 
can omit essential kinetic or thermodynamic information 
relevant to the process under study. Besides, choosing an 
appropriate set of DOFs requires a detailed knowledge of our 
system. Approaches to automatically reduce the 
dimensionality of the data while preserving as much 
information as possible have been developed. For example, 
Principal Component Analysis (PCA)24 performs a 
dimensionality reduction accounting for as much variance in 
the data set as possible. In a nutshell, if we define variance as 
the deviation of an atom from its mean position along the MD, 
then each principal component will be a linear combination of 
strongly correlated atomic motions with large oscillations. The 
resulting low dimensional PCA space can be used to 
reconstruct the associated free energy landscape (see Fig. 1A). 
For example, PCA has been applied in several studies of 
protein folding and allostery.25 However, transitions with the 
highest variance do not strictly correlate with the slowest (i.e. 
kinetically relevant) processes. Contrary to PCA, the time-
structure independent component analysis (tICA) seeks to 
lower the dimensionality of our data while minimizing the loss 
of kinetic information.26 This is done by considering the time 
correlation of the data instead of the variance. Alternative 
approaches to reduce dimensionality include Diffusion Maps,27 
the variational approach,28 and the Sketch-Map29 among 
others. 
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Fig. 1 Schematic view of the dimensional reduction process of multiple unbiased MD simulation data (A) and the main bias methods (B) used to construct the conformational Free 
Energy landscape. 
The time-dependent properties gathered from MD simulations 
can only be connected with experimental observables if all 
relevant states or conformations of the system are visited (i.e. 
ergodic principle).23 In practical situations, this is not normally 
the case. To properly integrate the equations of motion, 
atomistic MD calculations using empirical force fields typically 
use time steps of the order of femtoseconds (i.e. 10-15 
seconds), being able to compute few nanoseconds with a 
personal computer, but far from the millisecond to second 
timescales of domain motions and allosteric transitions 
occurring in some enzymes, as mentioned in the 
introduction.30 This time scale gap frustrates direct comparison 
with experimental data, encouraging for alternative 
approaches, which can be broadly classified in unbiased and 
biased methods. 
 
a. Unbiased MD methods 
 
After more than 40 years since the first MD simulation of a 
protein was performed,31 the basic MD algorithm remains 
unaltered. Then, the question is, how can we increase the 
accessible timescales to make reliable connections with 
experiments? Here we detail some of the most commonly 
used strategies:  
(i) CPU parallelization leads to an enormous increase in the 
accessible simulation timescales. This strategy is used to 
simulate extremely large systems during moderately long 
simulation time thanks to a divide and conquer approach (i.e. 
the system is broken down into smaller entities, each one 
being computed on the different connected CPU). This 
approach was used in a MD simulation of a complete solvated 
tobacco mosaic virus capsid with up to 1 million atoms.32  
(ii) The Anton supercomputer, which was specifically 
developed as a special purpose computer by D.E. Shaw and 
coworkers to perform single long MD simulations of biological 
systems. The first atomistic millisecond MD simulation of a 
WW protein domain was performed with Anton.33 This 
computer has also been used to study the fold of a series of 
small proteins,34 allosteric transitions in G-protein membrane 
receptors,35 and ligand binding kinetics36 among others. 
  (iii) GPU based clusters offer an affordable alternative to 
increase MD accessible timescales by running either single 
long and/or multiple short simulations of the same system. 
Some MD codes have been specifically designed to run on 
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GPU’s, such as AceMD,37  and OpenMM,38 whereas others 
have been ported to GPU’s (Amber,39 Gromacs,40 and 
NAMD41). The idea behind multiple MD runs is to promote 
infrequent transitions or rare events by running several MD 
simulations from different initial structures and combine them 
to recover the associated conformational free energy 
landscape (see Fig. 1A). However, dealing with the resulting 
flood of data, comprised of hundreds or even thousands of 
simulations, becomes a challenge. Markov State Models 
(MSMs) arise as an approach to analyse large MD data sets in 
an objective methodological way to recover thermodynamic 
and kinetic parameters between conformational states. MSMs 
are also based on a dimensional reduction (e.g. tICA) to 
recover the free energy landscape associated with slow 
collective DOFs and the kinetics of the process. Quantitative 
predictions from MSMs can be compared with available 
experimental data.42 In particular, this approach has recently 
been used to study serine protease Trypsin43 and Bruton 
tyrosine kinase conformational plasticity.44 Besides, MD 
simulations together with MSMs were also used to guide a 
regioselective switch in a nitrating P450 from Streptomyces 
scabies.45 
(iv) Replica exchange or parallel tempering46 is an 
alternative strategy based on running several copies of the 
same system at different temperatures and exchanging 
conformations at certain time intervals. Probability 
distributions are only meaningful at room temperatures and 
can be recovered by projecting atomic coordinates onto some 
selected DOFs (see Fig. 1A), as explained before, whereas high 
temperatures facilitate barrier crossing.  This approach has 
been widely used for protein folding,47 although the number of 
replicas required to ensure temperature exchanges is 
proportional to the number of atoms, thus making it 
unaffordable for large systems. 
 
 b. Biased MD methods 
 
It is possible to increase the frequency with which barriers 
separating stable states are crossed by introducing external 
energy potentials into our MD simulations. The selection of the 
proper biased method can be guided by the amount of 
structural information that we have about our system. For 
instance, to study the transition of a protein domain from an 
open (A) to a closed (B) conformation, two main questions can 
be formulated: 1) Do we have enough structural information 
of A and B to define some DOFs, (e.g. dihedral angles), 
describing the transition? 2) Do we have intermediate 
structures between the two states? Based on the answer to 
both questions a proper bias method can be chosen: 
 
(i) Only one conformational state is known (e.g. A) and, 
therefore, no clear information about the transition is 
available. In this situation, methods to explore biomolecular 
conformations without a priori structural knowledge, such as 
accelerated MD (aMD),48 are advantageous. In aMD, a bias 
potential (i.e. boost potential) is added to raise the energy 
minima while keeping high energy region almost unaffected, 
therefore, smoothing the free energy landscape and enhancing 
conformational exchanges (see Fig. 1B). aMD becomes really 
useful when few structural information is available, although a 
non-trivial post-processing is needed to recover unbiased free 
energy values. This method has been applied to fold a set of 
small proteins49 and to study the conformational dynamics of 
biomolecules, such as the maltose binding protein.50 
(ii) Both conformational states (A and B) are known, but no 
clear information about intermediate states is available. In this 
case, methods that explore all possible transitions between A 
and B along a set of DOFs (e.g. distance between two residues, 
the RMSD of a domain region) are the proper choice. 
Metadynamics51 is based on the addition, at a regular number 
of MD steps, of small repulsive potentials to a selected set of 
DOFs (see Fig. 1B). These potentials discourage the system 
from visiting prior configurations, forcing it to escape from 
energy minimum A to explore B through the lowest energy 
path. In addition to accelerate transitions between states, 
metadynamics allows to recover the free energy associated 
with the A to B transition by the sum of all the repulsive 
potentials added along the MD. This method usually provides 
higher accuracy than previous biased approaches, but can also 
experience convergence issues since it is not easy to decide 
when to stop a simulation, avoiding the addition of useless 
repulsive terms. It has the advantage that only a few structural 
information is required to set up the simulation, although 
choosing a proper set of DOFs can sometimes be tricky. 
Metadynamics has been widely used to study the 
conformational landscapes of proteins,52 and the effect of 
pathogenic mutations in cancer related kinases.52-53 
  (iii) Both conformational states (A and B) are known 
together with intermediate conformations. If detailed 
structural knowledge is available, independent MD simulations 
at states A and B together with a spectrum of intermediate 
conformations can be performed. In umbrella sampling (US),54 
for example, several MD simulations are computed with 
restraining bias potentials added at small increments along the 
reaction coordinate, forcing the system to sample all the 
desired conformational states, therefore cancelling the effect 
of energy barriers and exploring low probability regions (see 
Fig. 1B). Overlapping umbrella sampling simulations can be 
analysed together to recover probability distributions and the 
free energy within the A to B transition.55 This method 
provides good estimates of the free energy, since each point 
on the transition is equally sampled, but detailed structural 
knowledge is required to define a suitable set of starting 
conformations describing a continuous pathway between A 
and B.56 
3. Effect of mutations and/or ligand binding on 
the free energy landscape 
The free energy landscape reveals the multiple thermally 
accessible conformations other than the native state (i.e. 
lowest energy state) that the enzyme can adopt in solution. As 
described in the conformational selection model,57 all these 
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weakly populated conformations may be of importance for 
recognising the substrate. After inhibitor or substrate binding, 
a redistribution of the populations of the conformational 
states exists, i.e. a population shift occurs.57 Within the 
population shift or conformational selection concept, the 
binding event does not induce a conformational change, but 
rather a redistribution of the populations of the 
conformational states that already exist in the absence of 
ligand. This is in contrast to the 60-year old Koshland induced 
fit model,58 in which the binding of the substrate induces a 
conformational transition from the apo to the holo 
conformation of the enzyme. The induced fit model 
overlooked the fact that in solution the enzyme can pre-exist 
in multiple conformations in addition to the apo 
conformational state.59 In recent years, the population shift 
concept originated from the Monod-Wyman-Changeux model 
of allostery60 has become more popular than the induced fit 
model. Recently, Kovermann and coworkers provided evidence 
for a conformational selection pathway in the adenylate kinase 
(AdK) enzyme.61 As shown by X-ray crystallography, Adk 
adopts an open conformation in absence of ligand, whereas a 
catalytically competent closed conformation is required for 
catalysis. According to the conformational selection model, 
this high in energy closed conformational state should also be 
visited in the absence of ligand, albeit with a lower frequency. 
By introducing a disulfide bond, they succeeded in arresting 
AdK in a closed conformation in the apo state. The X-ray 
structure provided a definitive proof of the closed 
conformation of the enzyme being also sampled in the 
absence of any ligand, thus highlighting that higher in energy 
functionally relevant states are visited even in the apo state. 
  
Fig. 2 Schematic representation of the population shift induced by ligand binding 
and/or by the introduction of mutations in the enzyme free energy landscape.  
High in energy conformational states relevant for substrate 
binding can also be important for conferring the enzyme the 
ability to accelerate additional promiscuous reactions,4 or for 
the enzyme evolution towards novel function.11a, 13d, 62 Similar 
to substrate binding, introduction of mutations to the enzyme 
sequence can induce a shift in the populations of the pre-
existing conformational states (see Fig. 2). This was elegantly 
demonstrated with a recent example by Tokuriki and Jackson 
through an impressive collection of X-ray structures.11a They 
demonstrated that the change in function from a 
phosphotriesterase into an arylesterase is achieved by gradual 
population of pre-existing conformational states, i.e. a 
population shift occurs along the evolutionary pathway. Their 
study established that minor states that conferred the natural 
enzyme some arylesterase activity were gradually stabilised to 
become major states in the evolved arylesterases.11a A similar 
finding was obtained by Jackson in evaluating how ancestral 
binding proteins evolved into specialist binders.11b An ancestral 
arginine-binding protein was crystallised in complex with L-
arginine and L-glutamine revealing that the promiscuous 
binding of L-glutamine was possible due to alternative 
conformational states. These alternative conformational states 
were further populated along evolution to produce the 
contemporary L-glutamine specific protein binders. Finally, 
some of us were able to elucidate the role of distal mutations 
in recapitulating the allosteric regulation exerted by an acyl-
carrier protein on the acyltransferase enzyme LovD by means 
of MD simulations.7c, 13c The analysis of the conformational 
dynamics of the stand-alone LovD enzyme along the 
evolutionary pathway indicated that the introduced mutations 
induced a gradual population of the catalytically active 
conformational states. These studies support the idea that the 
underlying principle that guides enzyme evolution lies in the 
population shift of the conformational states that pre-exist in 
solution. 
 
The effect of introducing mutations to the enzyme 
sequence for their evolution towards new functions and novel 
substrate scope has a high similarity to substrate binding and 
allosteric regulation processes.11a, 62-63 In all cases, a 
redistribution of the populations of the conformational sub-
states exists, but in the particular case of enzyme evolution 
this population shift should favour the catalytically competent 
conformational states for the new target reaction. The 
challenge lies in the rational prediction of mutations required 
to favour the desired population shift. Different computational 
enzyme design strategies have been developed such as the 
inside-out protocol with Rosetta, 14a, 64 multi-state design,18a 
CASCO (Catalytic Selectivity by Computational design),65 and 
discrete molecular dynamics (DMD)66  to predict active site 
mutations. Some recent methodologies, based on empirical 
valence bond (EVB), have also been proposed to mimic the 
experimental directed evolution.67 EVB and quantum 
mechanics/molecular mechanics (QM/MM) calculations can be 
used to elucidate the effect of active site mutations on the 
catalytic activity of the enzyme regarding enzyme 
conformational dynamics.1c, 68 Additionally, the calculation of 
catalytically competent poses observed along MD 
simulations7c, 13c, 65 has been used to rationalise how active site 
and distal mutations affect the catalytic activity of enzymes 
(see reference 13b for a complete description of the available 
computational techniques for rationalising the effect of 
mutations on laboratory-evolved enzymes).  
Many examples have been provided in the literature 
demonstrating that mutations located at remote positions 
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from the active site can have a large impact on the catalytic 
activity of the enzyme.13c, 69 For instance, the effect of distal 
mutations has been nicely demonstrated experimentally and 
computationally in cyclophilin A.25b, 70 Indeed, no correlation is 
found between the influence of a given mutation on the 
catalytic constant of the enzyme and its proximity to the active 
site.71 Due to the broad sequence space of enzymes, the 
computational prediction of distal mutations has been proven 
to be challenging.13c, 69b The key role exerted by remote 
mutations on the active site of the enzyme suggests that 
allostery (.i.e. regulation of enzyme function by distal 
positions) might be an intrinsic characteristic of enzymes,72 
which might be exploited for enzyme evolution.13d As 
discussed in the next section, our group has recently shown 
that correlation-based tools usually employed for elucidating 
allosteric processes can be successfully applied in the enzyme 
design field, identifying key distal positions that might 
influence the enzyme activity.13d 
4. The population shift concept in enzyme 
evolution 
Among all available computational tools,13b MD simulations 
have been shown to be crucial for characterising the enzyme’s 
free energy landscape (FEL) and population shifts induced by 
mutations. In the next sections, we provide a series of 
examples based on MD that emphasise the importance of the 
population shift concept induced by both active site and distal 
mutations for: evolving the enzyme towards novel or 
promiscuous reactions, broadening its substrate scope, and 
reverting its enantioselectivity. 
 
a. Towards novel enzyme function 
Most of the examples provided in the previous sections are 
based on enzymes that present some residual (promiscuous)3 
activity for the reaction under interest. For instance, the 
evolution of a phosphotriesterase into an arylesterase was 
achieved by introducing mutations via DE to further enhance 
the activity for the second reaction.11a As previously described, 
these mutations modified the free energy landscape of the 
phosphotriesterase enzyme and enhanced its residual 
arylesterase activity by populating pre-existing conformational 
states. However, what if the original enzyme has no residual 
activity for the target reaction? There are many interesting 
reactions that have no precedent in Nature, which makes the 
enzyme design task quite challenging. In this scenario, de novo 
computational protocols have been shown to be extremely 
useful for designing new enzyme variants, based on different 
scaffolds, achieving some initial activity for the desired 
reactions.13b, 73  
One of the most representative cases of de novo 
computationally-designed enzymes was the creation of Kemp 
eliminases, which catalyse a proton abstraction from a carbon 
by a base. The first designs were generated using the inside-
out protocol16b that combines Rosetta software74 and the 
theozyme concept, although other designs employing other 
methodologies have also been published.75 The inside-out 
Kemp eliminases exhibited quite low activities, due to the lack 
of precision to generate the perfect arrangement of the active 
site for catalysis.2, 64 The different computational designs were 
further optimised through DE, making use of iterative design 
protocols that yielded new variants containing 10-15 
mutations and exhibiting higher activities.16b, 16d, 76 However, 
the most proficient Kemp eliminase reported so far was 
recently created by Kamerlin, Sanchez-Ruiz, and coworkers 
using an alternative approach. They showed that through a 
single hydrophobic-to-ionizable mutation an ancestral β-
lactamase could be efficiently converted into a Kemp 
eliminase.77 It was remarkable that with 1-2 mutations this 
new variant was more efficient in accelerating the Kemp 
elimination than any of the previously designed Kemp 
eliminases. Of particular interest for the topic of this feature 
article is that such high activities were achieved mainly due to 
the conformational flexibility of the ancestral enzyme. This 
study further confirms that conformational heterogeneity 
should be explicitly taken into account for computationally 
designing novel enzyme functions.  
A nice example of the importance of enzyme 
conformational dynamics and the population shift concept for 
acquiring new function was reported for retro-aldolases (RA). 
The inside-out protocol was applied for generating these 
mechanistically complex RA enzymes.16e The designed RAs 
catalyse the cleavage of methodol substrate by a multistep 
reaction involving a Schiff base intermediate, between the 
catalytic lysine and the substrate (see Fig. 3). Hilvert and 
coworkers applied DE on the computationally designed RAs to 
enhance their modest activities towards methodol cleavage. 
One of the most important mutations was the introduction of 
a new catalytic lysine on the binding pocket in the second 
evolved variant (RA95.5). The introduced mutations 
completely remodelled the active site allowing a better 
positioning of the Schiff base intermediate for catalysis. 
Recently, a highly active RA variant (RA95.5-8F) was generated 
after multiple rounds of DE, which exhibits comparable 
activities to those of natural class I aldolases.69a RA95.5-8F 
features a sophisticated catalytic tetrad responsible for the 
enhanced efficiency of the enzyme. These series of studies 
show the great power of DE in converting the original 
computational designs into highly proficient enzymes reaching 
activities similar to those of natural enzymes. It is worth 
mentioning that all these experiments were supported by X-
ray structures.69a  
The development of such a proficient RA enzyme, from the 
computational designs, prompted some of us to explore 
through microsecond timescale MD simulations the different 
RAs variants generated along the evolutionary pathway.13d The 
free energy landscape of the variants was reconstructed 
through the application of the PCA technique to the MD 
simulations (see Fig. 3). By measuring the distance between 
the base and the Schiff base intermediate in the different 
conformational states sampled along the MD simulations, we 
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were able to distinguish catalytically inactive and active 
conformational states (Fig. 3). The least active variant (i.e. the 
 
 
Fig. 3 Representation of the sampled conformations along the MD simulations as a function of the two most important principal components (PC1 and PC2) for three RA variants 
(RA95.0, RA95.5, and RA95.5-8F). The mean distance between the heteroatom of the base and the oxygen of the Schiff base is represented together with the standard deviation 
(in Å). Those states exploring distances in the 2.0−4.0 Å range are shown in green as active conformations and other states are shown in red as inactive conformations.
computational design RA95.0) sampled only a few catalytically 
active conformations. The population of the catalytically active 
conformational states was raised along the evolutionary 
pathway. The most prominent shift was observed for the last 
evolved variant showing that all the conformations explored 
were catalytically competent (RA95.5-8F). The analysis of the 
conformational landscape of the variants highlighted that the 
conformational heterogeneity of the computational and less 
evolved variants was tuned to progressively stabilise the 
catalytically active conformational sub-states, which become 
major in the most evolved variants. Interestingly, the RA 
intermediate variants that exhibit a high degree of 
conformational flexibility were found to be highly 
promiscuous.16h, 16i 
One of the biggest questions related to MD simulations is 
their predictive power, i.e. can we develop a MD-based tool 
capable of identifying a priori target residues to mutate for 
novel functionality? The alteration of enzyme function by 
introducing mutations is to some extent comparable to 
allosteric regulation, as mutations shift the populations of 
individual conformational sub-states of the enzyme. Given the 
high similitude of both processes we hypothesised that tools 
developed for studying allostery, (i.e. based on correlation 
measures from the MD simulations),78 could also be useful for 
enzyme design. Our group developed DynaComm.py python 
code that explores residue-by-residue correlated movements 
and inter-residue distances for predicting active site and distal 
positions that by mutation can induce a population shift.13d 
The output obtained is a shortest path map (SPM), which 
contains pairs of residues that have a higher contribution to 
the communication pathway. By comparing the outcome from 
SPM analysis with the positions mutated along the 
evolutionary pathway, we observed that our tool was able to 
predict most of the mutation points introduced in the different 
rounds of DE (see Fig. 4). Therefore, SPM is a very promising 
tool for the generation of “small but smart” libraries for the 
rational design of enzymes. The success of SPM in RAs may be 
related to the natural scaffold chosen, an indole 3-glycerol 
phosphate synthase, known to be an allosterically regulated 
enzyme.  Of note is that designed RAs are (βα)8 barrel 
enzymes, which is a fold shared by many enzymes in the 
Protein Data Bank,78 suggesting that the application of our tool 
might be quite broad. We are now testing the possibility of 
applying SPM tool to engineer other allosterically-regulated 
enzymes.  
 
Fig. 4 On the left, mutations introduced by DE to yield the last variant RA95.5-8F are 
represented. On the right, the shortest path map (SPM) analysis is represented for the 
variant RA95.5-8. Residues predicted are shown in teal, those predicted in adjacent 
positions in purple, and in orange those deviated more than five positions in sequence 
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from the path. In parenthesis, it is indicated how far is the residue in the sequence 
from the closest residue of the SPM. 
b. Towards novel substrate scope 
Substrate specificity is a crucial property of enzymes. 
Traditionally, the general idea that enzymes were restricted to 
accommodate only the ideal substrate was accepted, i.e. the 
famous lock and key model by Fischer.79 However, many 
natural enzymes are also capable of transforming a range of 
substrates related to its primary function, and thus present a 
broad substrate scope. Such enzymes are usually known as 
multi-specific enzymes. 80 
In general, laboratory evolution is applied to increase the 
ability of enzymes to accept bulkier substrates that are usually 
the precursors of compounds of pharmacological interest. It 
has been postulated that bulky substrates have a higher 
dependency on the conformational dynamics of the binding 
site, in contrast to small substrates that are better recognised 
in more conformationally restricted active site cages.81 By  
mutation the flexibility of the binding pocket can be 
modulated, (e.g. active site volume fluctuations), and 
conformational states more suitable for recognising and 
stabilizing a particular substrate can be populated. For 
instance, in the P450 enzyme family, CYP2A6 shows a quite 
narrow substrate scope, and is indeed quite rigid, whereas 
CYP3A4 is highly promiscuous and flexible.4  Particularly 
interesting is monoamine oxidase from Aspergillus niger 
(MAO-N) whose substrate scope was substantially enhanced 
by DE. The Turner lab evolved the wild-type enzyme and 
providing a series of variants that are capable of 
accommodating a variety small and bulky of chiral amine 
substrates. These variants present mutations not only 
restricted at the hydrophobic cage of the enzyme, but also at 
remote positions that impact the catalytic activity of the 
enzyme.82  
 
Epoxide hydrolases (EH) have been widely explored for 
engineering substrate selectivity. In this regard, Kong and 
coworkers were able to expand Bacillus megaterium EH 
(BmEH) substrate scope towards more sterically demanding 
epoxide substrates by introducing single mutations at positions 
located near the active site.83 EH enzymes catalyse the 
enantioselective hydrolysis of racemic epoxides to their 
corresponding vicinal diol. BmEH has attracted an increasing 
interest due to its (R)-selectivity towards phenyl glycidyl ethers 
(PGE),84 but also because some of its engineered variants 
display promising activities towards the propranolol precursor 
(i.e. naphthyl glycidyl ether, NGE), among other compounds of 
pharmacological interest.83 Because of the aforementioned, 
some of us decided to explore the conformational 
heterogeneity of BmEH wild-type and two single point variants 
using microsecond time scale MD simulations. We have 
recently observed how mutations introduced in non-catalytic 
positions of BmEH lead to relevant conformational 
rearrangements that are responsible for the acceptance of 
pharmacologically relevant bulky substrates. Using tICA as a 
dimensional reduction technique, we constructed the 
associated free energy landscape revealing that the wild-type 
enzyme can display four major conformational states.85 The 
analysis of these conformational states in combination with 
active site volume calculations, provided evidence that the 
most populated wild-type conformations, in which the 
catalytic machinery is well-positioned for catalysis,86 present 
small active site pocket volumes (see Fig. 5). However, 
interesting conformational changes were observed in higher in 
energy conformational states. Especially important is the 
dynamic behaviour of a loop containing one of the catalytic 
Asp239 that is able to adopt an open conformation, which 
leads to substantially wider active site volumes. We 
hypothesised that this conformational state, not previously 
reported in the literature, plays a key role in binding the 
phenyl glycidyl ether (PEG) substrate. In contrast to BmEH 
natural enzyme, single mutations introduced in the variants 
induced an extra partial disorder on some of the α-helices that 
surround the active site pocket of the enzyme (particularly 
important is the α-helix that contains the catalytic Tyr144). 
Interestingly, this mutation-induced disorder in combination 
with the catalytic Asp239 loop opening seem to be key for the 
acceptance of bulkier epoxides (i.e. NGE) in these engineered 
variants (see Fig. 5). 
 
Fig. 5 Representative conformational states sampled along the MD simulations for the 
BmEH wild-type and variant together with the constructed free energy landscape. 
Representative conformational states key for the binding of the epoxide substrate are 
indicated in the free energy landscape in pink and blue (conformations 3 and 4 for wild-
type and variant, respectively). Loop and α-helix are highlighted in orange and green, 
respectively, and active-site volumes are shown in blue as surface mode. 
As noted in the introduction, DE experiments usually result 
in the insertion of multiple mutations remote from the active 
site. 13c, 69 In most cases, the direct effect of distal mutations 
on the catalytic properties of the enzymes is hard to 
rationalise. In a very recent study, some of us explored how 
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distal mutations introduced via DE converted a D-sialic acid 
aldolase into an L-KDO aldolase.87 D-sialic acid aldolase is a 
dimeric enzyme complex that catalyses the reversible aldol 
reaction of N-acetyl-D-mannosamine (ManNAc) and pyruvate 
to produce D-sialic acid via an ordered sequential Bi-Uni kinetic 
mechanism. The engineered L-KDO enzyme variant accepts the 
smaller L-arabinose substrate to perform the reaction. 
We explored the free energy landscape of both D-sialic and 
L-KDO aldolase and identified that distal mutations led to a 
population shift in the conformational states sampled.88 In 
both enzymes, only one of the two conformational states 
displayed an active site well pre-organised for the catalysis 
(see Fig. 6). Most importantly, the analysis of substrate 
accessibility, active site interactions, and tunnel calculations on 
the conformational states sampled by the enzymes provided 
new insights into the change of specificity induced by 
mutation. Interestingly, the conformational states of L-KDO 
aldolase present much narrower active site and substrate 
access tunnels, which induce a change in the substrate scope 
of the enzyme. In the L-KDO aldolase, the access of the bulkier 
natural substrate into the enzyme active site is substantially 
more hindered, as shown by the computed substrate access 
barriers on the different conformational states. Of particular 
importance is the distal mutation introduced at V251 position, 
which is located at the bottleneck of the substrate access 
channel. Remarkably, among all introduced mutations in the 
DE experiment mutation, V251I was shown to play the most 
important role.89 
 
Fig. 6 Representation of the conformational states sampled along the MD simulations 
for D-sialic and L-KDO aldolase rearrangements together with the active site volume 
calculations and the computed free energy landscape from PCA. Mutations are shown 
as pink spheres. The position V251 of binding pocket and catalytic residues are shown 
in sticks (the catalytic tyrosine residue from the other chain of the dimer is highlighted 
in purple).  
c. Towards novel enantioselectivity 
Natural enantioselective enzymes evolved to act on pro-chiral 
substrates for precisely yielding the optically pure enantiomer 
requested. Even though enzymes exist in multiple 
conformations, this conformational heterogeneity does not 
translate into a lack of enantioselectivity. In fact, the 
conformations explored by enzymes present stable binding 
pocket conformations that favour the formation of only one 
particular enantiomer. In this dynamic view of enzymes, 
reversing their enantioselectivity requires the introduction of 
mutations to alter the conformational energy landscape, which 
should preferentially favour the formation of the desired 
enantiomer. 
A powerful experimental method to enhance 
enantioselectivity and to expand substrate scope consists of a 
semi-rational DE approach applying iterative saturation 
mutagenesis (ISM) on a reduced set of relevant active site 
amino acids (CASTing).90 Second-sphere and distal mutations 
can also lead to a re-shaped binding pocket through allosteric 
effects.90c Theoretical QM/MM calculations and MD 
simulations are promising tools to discern the factors 
governing the improvement in enzyme enantioselectivity on a 
molecular level.13b Most of the computational evaluation 
studies are based on quantifying the frequency of the 
catalytically productive pro-(S) and pro-(R) orientations, which 
can be done by monitoring some selected angles and distances 
between the substrate and important active site residues 
along the MD simulations.65, 91 By combining computational 
design with short MD simulations, Janssen and Baker 
successfully (re)designed the active site of an epoxide 
hydrolase obtaining enhanced enantioselectivities.65 Recent 
studies have shown that the analysis of enzyme structure 
flexibility (through root mean square fluctuation, RMSF) along 
MD simulations can be used to identify key functionality in 
loop regions adjacent to the binding pocket.91c, 92 By 
modulating the conformational dynamics of these loops the 
reversal of enantioselectivity can be achieved.92b 
One of the most explored enzymes for the reversal of 
enantioselectivity are alcohol dehydrogenases (ADH). ADHs 
are zinc-dependent enzymes that use NAD(P)H as a cofactor, 
which delivers its hydride ion to the carbonyl group on the Re 
or Si-face of the pro-chiral ketone substrate yielding the 
corresponding (S) or (R)-alcohol (see Scheme 1). 
 
Scheme 1. Representation of the pro-(R) and pro-(S) hydride attack for substrate 1a, 
together with the experimentally reported enantioselectivity of the engineered 
variants TbADHW110T and TbADHI86A by Reetz and coworkers. 93 
In an inspiring study from Lamed and coworkers, the active 
site shape of a thermophilic ADH enzyme from 
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Thermoethanolicus brockii (TbSADH) was speculated. They 
suggested that its structure would consist of two differently-
sized active site pockets, one being larger than the other to 
accommodate the bulkier alkyl group of the pro-chiral ketone 
substituent.94 Interestingly, this hypothesis was later 
confirmed with the resolution of the crystal structure.95 
Phillips rational site-specific mutagenesis studies indeed 
reported that by changing the size of the active site pockets 
the enantioselectivity and the substrate scope of the enzyme 
can be modulated.96 Reetz and coworkers successfully 
engineered the enantioselectivity of TbSADH on a rich array of 
substrates by applying CASTing, guided by the available crystal 
structure and Phillips studies.93, 97 
In most experimental studies published, W110 and I86 
positions located at the active site have been found to be key 
for enhancing the activity and reversing the enantioselectivity 
towards diverse bulky ketones.93, 96-98 We hypothesised that 
these single point mutations might induce a significant shift on 
the conformations sampled by the enzyme, which may enable 
the accommodation of non-natural substrates and 
preferentially favour the formation of one enantiomer over 
the other. To shed further light on the enhanced 
enantioselectivity contribution of these two mutations, we 
decided to evaluate the conformational dynamics of wild-type 
TbSADH, and the singly-mutated TbSADHW110T and TbSADHI86A 
variants in the presence of the pro-chiral ketone 4-alkediene 
cyclohexanone (1a, see Scheme 1) studied by Reetz and 
coworkers.93 Experimentally, it was found that TbSADH is able 
to produce the corresponding (R)-alcohol but only with modest 
enantioselectivity (66 (R) %ee). In contrast, TbSADHW110T 
exhibited (R)-enantioselectivity with 97 (R) %ee, whereas 
TbSADHI86A reversed enantioselectivity with 98 (S) %ee.93 Our 
MD simulations constrained the substrate 1a bound to the Zn 
metal ion by imposing a force constant within the bonded 
model.91b, 99 This approach allows us to rationalise the 
preferences of the accommodation of 1a in the active site 
along the simulation time. MD simulations coupled to active 
site volume calculations with POVME100 and the analysis of the 
most relevant non-covalent interactions with NCIplot101 
permits to elucidate how favourable are the pro-(R) and pro-
(S) conformations.91b 
 
Fig. 7 Representation of the different conformational states sampled along the MD 
simulations for the TbADHW110T and the TbADHI86A enzyme variants, together with the 
representative snapshots of pro-(R) and pro-(S) conformations. High and low angle (in 
degrees) values represent pro-(R) and pro-(S) conformations, respectively. Short 
hydride transfer distances (in Å) values above the dashed line indicate catalytically 
productive orientations. Compound 1a is shown in purple and pink for the pro-(R) and 
pro-(S) poses, respectively. 
The conformational states sampled by the wild-type 
enzyme can position 1a in a catalytically competent 
orientation for both pro-(R) and pro-(S) hydride transfer, thus 
leading to a poor enantioselectivity. The substitution of W110 
by threonine alters the large binding pocket of the 
conformational states sampled, becoming even wider (see Fig. 
7). The extra space released after mutation stabilises those 
conformational states that adopt the catalytically productive 
pro-(R) positioning of the ketone. In contrast, the substitution 
of I86 by alanine enlarges the small binding pocket, thus 
favouring the population of those conformational states that 
better accommodate the pro-(S) productive orientation of 1a 
(see Fig. 7).  The analysis of the non-covalent interactions 
occurring on the most populated conformational states 
sampled revealed how the active site pocket is remodelled to 
better stabilise the pro-(S) or pro-(R) orientations.91b These 
recent advances highlight the feasibility of MD simulations 
coupled with other computational tools for the engineering of 
natural enzyme active sites for enhanced enantioselectivity. 
Conclusions and perspectives 
As anticipated by Tokuriki and Tawfik a few years ago, 
conformational dynamism and evolvability are highly 
intertwined. 4 This feature article provides multiple examples 
highlighting the key role played by the enzyme conformational 
dynamics for its function, specificity, and enantioselectivity, 
but also for its evolvability. Laboratory and naturally evolved 
enzyme variants have taught us that rarely populated, high 
energy, conformational states can be gradually enriched, 
becoming predominant in the most evolved variants. In other 
words, unexpected enzyme capabilities, related to hidden 
conformational states, can override natural enzyme functions 
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by introducing mutations to enhance their relative 
populations. 
Recent studies on ancestral enzyme reconstruction have 
also provided key information on how evolution has achieved 
our actual enzymes.11a The large conformational heterogeneity 
found in ancestral enzymes and their ability to accelerate a 
wide range of promiscuous reactions contrasts with specialised 
enzymes that have low levels of promiscuity and restricted 
conformational dynamics.80 By taking advantage of the high 
level of conformational flexibility and promiscuity of ancestral 
enzymes, the generation of novel enzyme function can be 
achieved with a few mutations, as shown by Kamerlin, 
Sanchez-Ruiz, and coworkers with the Kemp elimination.77 We 
agree that the Kemp elimination is a rather simple reaction, 
but still the fact that the new variants based on ancestral 
scaffolds are more active than any of the previously evolved 
variants is highly appealing.  
 
Current computational strategies are not capable of 
designing enzymes as active as the natural and/or laboratory-
engineered variants.14a Semi-rational approaches have been 
shown to be more successful in this regard.2, 16a In these semi-
rational strategies, computational protocols are used to confer 
the enzyme some initial activity, which is then further 
enhanced by laboratory evolution. In this laboratory evolution, 
the catalytically competent conformational states are then 
gradually populated, as shown in many examples in this 
review. However, what if the enzyme conformational 
dynamics were taken more carefully into consideration in the 
computational protocol?  
 
We believe that the field of computational enzyme design 
could benefit from the following considerations: 
(i) Proper selection of the best enzyme scaffold for the 
target reaction. This should not be based on a static X-ray 
structure, but rather based on the conformational dynamics of 
the enzyme, and how competent the different conformational 
states that already pre-exist in solution are for our target 
reaction and/or substrates. This, of course, requires a 
thorough analysis of the free energy landscape of many 
different enzymes, which has a high computational cost 
associated.  
(ii) Mutation points should be determined for enhancing 
the populations of the competent conformational states, and 
for optimising the chemical steps. Existing computational 
protocols can properly predict active site mutations for 
stabilising the transition states of the desired reactions. 
Improvements in the active site description of the enzyme 
with EVB and hybrid QM/MM approaches could bring more 
accurate predictions,13b albeit with a substantially higher 
computational cost. Directed evolution (DE) has shown that 
both active site and distal mutations are needed for enhanced 
activity. Given the vast number of possibilities that should be 
taken into account, distal mutations (i.e. allosteric networks) 
are not usually contemplated in computational enzyme design. 
As shown in this review, our group has developed new tools 
for the prediction and generation of “small but smart” libraries 
based on active site and distal mutations.13d 
(iii) Improved enzyme ranking protocols based on machine 
learning algorithms. In most of current enzyme design 
computational protocols, there is no consensus on which are 
the most important computational parameters for enzymatic 
activity. The computational scores generated by the enzyme 
design software,13b together with the massive amount of data 
from the MD simulations of the engineered variants makes not 
straightforward the selection of the best variants. The 
application of chemoinformatic models and machine learning 
algorithms similarly as in the field of DE,69b could substantially 
improve the odds of finding the most beneficial mutations for 
activity.  
 
Our hypothesis is that careful introduction of the above-
mentioned considerations into available computational 
protocols, together with improvements in the available 
algorithms, methods, and hardware will bring the ‘emerging 
field’ of computational enzyme design one step forward.  
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Enzymes	exist	as	a	dynamic	ensemble	of	conformations,	each	potentially	playing	a	key	
role	in	binding	the	substrate,	performing	the	main	chemical	reactions,	and	releasing	
the	product.	By	mutation,	the	relative	populations	of	these	conformations	can	be	
altered	to	allow	novel	functions,	enhance	additional	side	reactions,	expand	the	
substrate	scope,	and	even	revert	the	enzyme	enantioselectivity.	
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